Caption Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-87,900
Closed -$1.22M 1934
2024
Q4
$1.22M Buy
+87,900
New +$1.39M 0.01% 858
2024
Q1
Sell
-44,600
Closed -$1.62M 1593
2023
Q4
$1.62M Sell
44,600
-19,300
-30% -$743K 0.02% 674
2023
Q3
$3.08M Buy
63,900
+49,000
+329% +$2.91M 0.05% 472
2023
Q2
$1.02M Buy
+14,900
New +$961K 0.02% 659
2023
Q1
Sell
-35,000
Closed -$2.11M 1453
2022
Q4
$2.11M Buy
+35,000
New +$2.05M 0.03% 548
2021
Q3
Sell
-30,000
Closed -$1.54M 1736
2021
Q2
$1.54M Buy
30,000
+20,000
+200% +$624K 0.02% 777
2021
Q1
$252K Buy
+10,000
New +$188K 0.01% 895

Other funds holding PRTA

Caption Management's PRTA Position: Q1 2026 in Review

Caption Management sold out of Prothena Corp (PRTA) in Q1 2026, closing a stake of 61,009 shares — an estimated $583K sold.

Caption Management first reported a position in PRTA in Q1 2021 and held it in 6 quarters. The position peaked at $1.67M in Q4 2023. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.

  • Caption Management reported no remaining Prothena Corp position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 61,009 Prothena Corp shares in Q1 2026, an estimated $583K.
  • Caption Management first reported a position in Prothena Corp in Q1 2021 and held it in 6 quarters.
  • Caption Management's Prothena Corp position peaked at $1.67M in Q4 2023.
  • 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.